Jane Street’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,500
| Closed | -$640K | – | 10701 |
|
|
2025
Q2 | $640K | Buy |
+6,500
| New | +$615K | ﹤0.01% | 6485 |
|
|
2023
Q4 | – | Sell |
-5,300
| Closed | -$495K | – | 9136 |
|
|
2023
Q3 | $495K | Sell |
5,300
-25,400
| -83% | -$2.35M | ﹤0.01% | 6321 |
|
|
2023
Q2 | $2.81M | Buy |
30,700
+26,200
| +582% | +$2.15M | ﹤0.01% | 3618 |
|
|
2023
Q1 | $331K | Sell |
4,500
-2,700
| -38% | -$234K | ﹤0.01% | 7029 |
|
|
2022
Q4 | $601K | Sell |
7,200
-16,400
| -69% | -$1.48M | ﹤0.01% | 5816 |
|
|
2022
Q3 | $2.28M | Buy |
23,600
+12,000
| +103% | +$1.43M | ﹤0.01% | 3966 |
|
|
2022
Q2 | $1.22M | Sell |
11,600
-48,500
| -81% | -$6.2M | ﹤0.01% | 5107 |
|
|
2022
Q1 | $10.4M | Buy |
60,100
+32,500
| +118% | +$4.86M | ﹤0.01% | 1947 |
|
|
2021
Q4 | $4.47M | Buy |
27,600
+25,800
| +1,433% | +$4.15M | ﹤0.01% | 3037 |
|
|
2021
Q3 | $268K | Sell |
1,800
-39,300
| -96% | -$8.17M | ﹤0.01% | 8398 |
|
|
2021
Q2 | $10.1M | Buy |
41,100
+38,600
| +1,544% | +$10.1M | ﹤0.01% | 1697 |
|
|
2021
Q1 | $662K | Sell |
2,500
-9,200
| -79% | -$2.59M | ﹤0.01% | 6266 |
|
|
2020
Q4 | $3.43M | Sell |
11,700
-44,800
| -79% | -$11.5M | ﹤0.01% | 2626 |
|
|
2020
Q3 | $13.4M | Buy |
56,500
+21,500
| +61% | +$4.89M | 0.01% | 1011 |
|
|
2020
Q2 | $6.95M | Buy |
35,000
+23,200
| +197% | +$4.33M | 0.01% | 1493 |
|
|
2020
Q1 | $2.17M | Buy |
+11,800
| New | +$2.1M | ﹤0.01% | 1943 |
|
|
2019
Q2 | – | Sell |
-2,000
| Closed | -$247K | – | 5088 |
|
|
2019
Q1 | $247K | Buy |
+2,000
| New | +$251K | ﹤0.01% | 4452 |
|
|
2017
Q1 | – | Sell |
-20,000
| Closed | -$853K | – | 4082 |
|
|
2016
Q4 | $853K | Buy |
+20,000
| New | +$850K | ﹤0.01% | 2251 |
|
Other funds holding AMED
IA
MCI
HNB
Jane Street's AMED Position: Q3 2025 in Review
Jane Street sold out of Amedisys (AMED) in Q3 2025, closing a stake of 48,371 shares — an estimated $4.76M sold.
Jane Street first reported a position in AMED in Q2 2014 and held it in 26 quarters. The position peaked at $15.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Jane Street reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 48,371 Amedisys shares in Q3 2025, an estimated $4.76M.
- Jane Street first reported a position in Amedisys in Q2 2014 and held it in 26 quarters.
- Jane Street's Amedisys position peaked at $15.5M in Q2 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.